Divergence of protection induced by bacterial products and sepsis-induced immune suppression

被引:23
作者
Sterns, T [1 ]
Pollak, N [1 ]
Echtenacher, B [1 ]
Männel, DN [1 ]
机构
[1] Univ Regensburg, Inst Immunol, D-93042 Regensburg, Germany
关键词
D O I
10.1128/IAI.73.8.4905-4912.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Susceptibility to bacterial infections after a primary immune stimulation differs drastically depending on the presensitization of the innate immune system. To determine the conditions that either induce protection or enhanced susceptibility to infection with Salmonella enterica serovar Typhimurium, we pretreated mice either with tumor necrosis factor (TNF), whole killed bacteria, or sublethal cecal ligation and puncture (CLP) as a mouse model for septic peritonitis. Impaired production of the cytokines TNF, interleukin-6 (IL-6), and IL-10 was induced by these pretreatment schedules, with TNF-signaling not being essential for this effect. Injection of TNF or killed bacteria enhanced survival of mice infected subsequently with serovar Typhimurium. In contrast, sepsis such as that induced by CLP only protected from shock induced by D-galactosamine and lipopolysaccharide or by a high dose of bacteria but sensitized to a secondary bacterial infection. Such sepsis-induced enhanced susceptibility to infection was critically dependent on TNF function.
引用
收藏
页码:4905 / 4912
页数:8
相关论文
共 45 条
[1]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE [J].
BONE, RC ;
SPRUNG, CL ;
SIBBALD, WJ .
CRITICAL CARE MEDICINE, 1992, 20 (06) :724-726
[2]   Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 [J].
Burns, K ;
Janssens, S ;
Brissoni, B ;
Olivos, N ;
Beyaert, R ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :263-268
[3]   Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense [J].
Chen, GH ;
Reddy, RC ;
Newstead, MW ;
Tateda, K ;
Kyasapura, BL ;
Standiford, TJ .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6496-6503
[4]   Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses [J].
Deiters, U ;
Gumenscheimer, M ;
Galanos, C ;
Mühlradt, PF .
INFECTION AND IMMUNITY, 2003, 71 (08) :4456-4462
[5]   Treatment of experimental sepsis-induced immunoparalysis with TNF [J].
Echtenacher, B ;
Urbaschek, R ;
Weigl, K ;
Freudenberg, MA ;
Männel, DN .
IMMUNOBIOLOGY, 2003, 208 (04) :381-389
[6]   Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis [J].
Echtenacher, B ;
Männel, DN .
JOURNAL OF ENDOTOXIN RESEARCH, 2002, 8 (05) :365-369
[7]  
ECHTENACHER B, 1990, J IMMUNOL, V145, P3762
[8]   Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice [J].
Echtenacher, B ;
Weigl, K ;
Lehn, N ;
Männel, DN .
INFECTION AND IMMUNITY, 2001, 69 (06) :3550-3555
[9]   DECREASED SENSITIVITY TO TUMOR-NECROSIS-FACTOR BUT NORMAL T-CELL DEVELOPMENT IN TNF RECEPTOR-2-DEFICIENT MICE [J].
ERICKSON, SL ;
DESAUVAGE, FJ ;
KIKLY, K ;
CARVERMOORE, K ;
PITTSMEEK, S ;
GILLETT, N ;
SHEEHAN, KCF ;
SCHREIBER, RD ;
GOEDDEL, DV ;
MOORE, MW .
NATURE, 1994, 372 (6506) :560-563
[10]  
Feterowski C, 2001, EUR J IMMUNOL, V31, P1268, DOI 10.1002/1521-4141(200104)31:4<1268::AID-IMMU1268>3.0.CO